Earnings ·
Accendra Health reported second quarter 2026 financial results, posting $613.2 million in net revenue and a GAAP loss…
ACHAccendra Health Inc
Accendra Health reported second quarter 2026 financial results, posting $613.2 million in net revenue and a GAAP loss from continuing operations of $89.1 million ($1.16 per share). The company reduced total debt by $385 million through a balance sheet optimization transaction completed in June, which included the issuance of new secured notes due 2032 and 2033. CEO Edward A. Pesicka announced his intention to retire by the end of 2026. Full-year 2026 guidance was updated to $2.45–$2.55 billion in revenue, $300–$320 million in adjusted EBITDA, and breakeven to slightly positive free cash flow. Accendra Health operates in the home healthcare industry, providing products and services for chronic conditions such as diabetes, sleep health, and respiratory care.